Access BNP II
Test, Natriuretic Peptide. 510(k) K262597, from Beckman Coulter, Inc. (Chaska, MN). Product code NBC, class 2.
As of Nov 17, 2026, K262597 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Oct 20, 2026 after 85 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Oct 20, 2026
- Review time: 85 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Access BNP II test is intended for use with the Beckman Coulter Access Family of Immunoassay Systems for the In Vitro quantitative measurement of B-type natriuretic peptide (BNP) in plasma specimens using EDTA as the anticoagulant.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
Other NBC Clearances
The newest 510(k)s for the same product code; their median review was 262 days; see every NBC device- Access NT-proBNPK262109 · Beckman Coulter, Inc. · Sep 21, 2026
- Access BNP IIK252169 · Beckman Coulter, Inc. · Mar 24, 2026
- Alere NT-proBNP for Alinity iK253539 · Axis-Shield Diagnostics, Ltd. · Feb 18, 2026
- Alere NT-proBNP for Alinity i Reagent KitK241176 · Axis-Shield Diagnostics, Ltd. · Jan 16, 2025
- Access NT-proBNPK232164 · Beckman Coulter, Inc. · Apr 12, 2024
- ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · Siemens Healthcare Diagnostics, Inc. · Sep 24, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK223637 · Roche Diagnostics · Jul 21, 2023
- Elecsys proBNP II, Elecsys proBNP II STATK210546 · Roche Diagnostics · Mar 31, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 27, 2026
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1117
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files